RACHIDETOU NJOYA: Open Payments
NPI 1215655923 · BELTSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 17 payments from 5 companies in 2025. Trend: 2023 $24 · 2024 $96 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $168 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $94 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Alkermes, Inc. | 3 | $60 |
Products named: COBENFY, CAPLYTA, ABILIFY MAINTENA, UZEDY, REXULTI, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
